Seeing nature through a molecular engineer’s eye
Alfredo Alexander-Katz probes systems in action, from clotting blood to walking molecules.
Alfredo Alexander-Katz probes systems in action, from clotting blood to walking molecules.
Four new projects and one renewal receive $150,000 in funding for 2016-2017.
Study finds enzyme “cannibalizes” itself to perform an essential reaction.
New chip could help test drugs for ALS, other neuromuscular disorders.
PhD student Tim Wang uses CRISPR to take a big-picture approach to cancer research.
System would use microbes for manufacturing small amounts of vaccines and other therapies.
New study reveals a link between circadian clock disruption and tumor growth.
Largest metagenomic view of the developing world uncovers “mobile genes” that reveal how culture shapes the human microbiome.
Analysis of ant colony behavior could yield better algorithms for network communication.
Biologists find a possible explanation for why the drug helps bipolar patients.
Associate Professor Ernest Fraenkel uses biological network modeling to identify new targets for disease.
Low-intensity fields keep malignant cells from spreading, while preserving healthy cells.
Tests in mice show the vaccines work against Ebola, influenza, and a common parasite.
Computer model finds slits in the spleen impose a “physical fitness test” on red blood cells.